article thumbnail

Press Release: Global Wellness Signs Definitive Agreement with Cannvalate Australia

Cannabis Law Report

from 2020 to 2030 and generate revenue of $151.7 billion in 2030. Cannvalate is a leader in the science, development and commercialization of cannabinoid-based prescription medicines with a large patent portfolio of novel cannabinoid and psychedelic drugs. 2 Pain 1994 Apr;57(1):5-15. 3 Psychol Res Behav Manag.

article thumbnail

Press Release: Global Cannabis Testing Services Market to Surpass US$ 4,527.6 Million by 2030, Says Coherent Market Insights (CMI)

Cannabis Law Report

4 % during the forecast period (2022-2030 ). Based on test type, cannabinoid profiling segment is estimated to grow with the fastest CAGR in the global cannabis testing services market over the forecast period, owing to increasing analysis of cannabis to detect its medicinal uses. Merck KGaA, Shimadzu Corporation, PerkinElmer, Inc.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Global Cannabis Market Size & Forecast Report 2021: A $176 Billion by 2030 – Growing Legalization of Medical Cannabis in Various Countries Driving Growth – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Global Cannabis Market- Market Size & Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. million by 2030 at a CAGR of 23.9%, 2021-2030. The global cannabis market in the COVID-19 period has been estimated to value USD 25,650.4

Indica 40
article thumbnail

State Agency Envisions Cannabis Cultivation Boosting Job Growth in Alaska

Veriheal

The Alaska Department of Labor foresees marijuana cultivation steering all of the state’s industries regarding job growth between now and 2030. Based on the latest employment trend report issued by Alaska’s labor department, marijuana cultivation will experience the most tremendous growth.

article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

To IGC’s knowledge, this is the first human clinical trial using low doses of natural THC, a psychoactive member of the cannabinoid class of natural products produced by the Cannabis sativa plant, on Alzheimer’s patients. This multi-step process for obtaining FDA approval is described in IGC’s annual report on Form 10-K filed with the U.S.

article thumbnail

Jushi Holdings Inc. Expands Product Offerings with Launch of Its First Line of Solventless Cannabis Extracts

Cannabis Law Report

Cacioppo went on to say, “Solventless products represent the pinnacle of extraction, as they capture the fullest expression of cannabinoids, terpenes, and flavonoids unique to each cultivar in concentrated form. billion by 2030. About Jushi Holdings Inc.

article thumbnail

New Mexico’s Cannabis Legislation: Key Bills to Watch

Canna Law Blog

HB 346 – Regulation of Hemp Products and Synthetic Cannabinoids HB 346 amends the states hemp laws to address a regulatory chasm concerning finished hemp products. This bill also mandates that the CCD receive and maintain these background reports.